Checkmate Pharmaceuticals
Why Robinhood?
You can watch CMPI and buy or sell other stocks, ETFs, and their options commission-free!About CMPI
Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies.
CMPI Key Statistics
Stock Snapshot
The current Checkmate Pharmaceuticals(CMPI) stock price is $10.50, with a market capitalization of 231.4M. The stock trades at a price-to-earnings (P/E) ratio of -3.60.
Checkmate Pharmaceuticals(CMPI) stock opened on 2026-07-28 at —. The price climbed to — and dipped to —.
The Checkmate Pharmaceuticals(CMPI)'s current trading volume is 0, compared to an average daily volume of 145.25K.
During the past year, Checkmate Pharmaceuticals(CMPI) stock moved between $2.00 at its lowest and $10.50 at its peak.
During the past year, Checkmate Pharmaceuticals(CMPI) stock moved between $2.00 at its lowest and $10.50 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.